News

Russian pharmaceutical company AKRIKHIN announces the financial results for
the first half of the year 2013 prepared in accordance with the Russian
Accounting Standards (RAS).

AKRIKHIN and MSD are expanding their partnership within the scope of MSD product manufacturing localization strategy in Russia. In 2012, the partners have signed an agreement on the production of 6 key MSD brands in various pharmaceutical forms and dosages at AKRIKHIN manufacturing site. Now, as the second wave of the contract, AKRIKHIN starts to manufacture 5 additional MSD brands important for local healthcare system.

AKRIKHIN will participate in the international pharmaceutical forum and exhibition IPhEB&CPhI Russia, April 10-11, 2013, held in Manège Central Exhibition Hall in Saint Petersburg.

In the annual rating of influence of the Russian pharmaceutical market entities, conducted by the newspaper «Pharmatsevticheskiy vestnik» at year-end 2012 AKRIKHIN took the third position. AKRIKHIN is nominated in the category «Local Pharmaceutical Manufacturer».